SCHEMBL1784359

SCHEMBL1784359

CNc1ccc(C(=O)C2=C(O)c3sc(NC(C)=O)nc3CC2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.40
NNMT P40261 1/20 0.39
PIK3CG P48736 6/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
OGA O60502 4/20 0.35
MAPT P10636 3/20 0.34
LMNA P02545 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 1/20 0.34
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
APP P05067 1/20 0.33
KDM4E B2RXH2 1/20 0.33
DYRK1A Q13627 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1117940 0.92 HCAR3 (0.43) HCAR3NNMTSMN1; SMN2MAPTHPGD
SCHEMBL1782452 0.90 HCAR3 (0.44) HCAR3PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL4550801 0.90 TSHR (0.39) HCAR3NNMTPIK3CGPIK3CDPIK3CA
SCHEMBL1782768 0.89 HCAR3 (0.43) HCAR3PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL1783767 0.89 PIK3CG (0.39) PIK3CGPIK3CDPIK3CAPIK3CBOGA
SCHEMBL1783498 0.89 HCAR3 (0.43) HCAR3PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL1781491 0.88 PIK3CG (0.42) PIK3CGPIK3CDPIK3CAPIK3CBSMN1; SMN2
SCHEMBL1117947 0.87 HCAR3 (0.42) HCAR3NNMTAPP
SCHEMBL1118036 0.87 HCAR3 (0.36) HCAR3NNMTSMN1; SMN2MAPTALDH1A1
SCHEMBL1781217 0.87 PIK3CG (0.43) PIK3CGPIK3CDPIK3CAPIK3CBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304556-B2 Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-06 US disclosed
US-8304556-B2 Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-11-06 US disclosed
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-03 US disclosed
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-03 US disclosed
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-19 US disclosed
CN-102015728-A Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INT 2011-04-13 CN disclosed
WO-2009112565-A1 THIAZOLYL-DIHYDRO-INDAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108567-A1 Thiazolyl-Dihydro-Indazoles MKI67, CYP11B1, IGF1R HCAR3 2774/4885NNMT 1096/4885PIK3CG 4280/4885
US-20110118208-A1 Thiazolyl-Dihydro-Indazoles MKI67, CYP11B1, IGF1R HCAR3 2774/4885NNMT 1096/4885PIK3CG 4280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.